Headache in women

Primary Care - Clinics in Office Practice

Volumn 31, Issue 2, 2004, Pages 417-428

  Johnson, Constance J ^a  

^a Headache Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTALBITAL; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; DEXAMETHASONE; ELETRIPTAN; ERGOTAMINE DERIVATIVE; ESTROGEN; FROVATRIPTAN; IBUPROFEN; INDOMETACIN; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROCHLORPERAZINE; PROGESTERONE; RECOMBINANT HORMONE; RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TESTOSTERONE; TOPIRAMATE; UNINDEXED DRUG; ZOLMITRIPTAN;

CEREBROSPINAL FLUID; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; FEMALE; FETUS DISEASE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; INTRACRANIAL PRESSURE; LUMBAR PUNCTURE; MENOPAUSE; MENSTRUAL IRREGULARITY; MENSTRUATION; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL CONTRACEPTION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SHUNTING; SPONTANEOUS ABORTION; TENSION HEADACHE;

BREAST FEEDING; CHRONIC DISEASE; CLUSTER HEADACHE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEADACHE; HEADACHE DISORDERS; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; MIGRAINE DISORDERS; PREGNANCY; PRIMARY HEALTH CARE; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; TENSION-TYPE HEADACHE; UNITED STATES; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 2542494817     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2004.02.012     Document Type: Review

References (30)

1. Rasmussen B.K., Lipton R.B. Epidemiology of headache. Olesen J., Tfelt-Hansen P., Welch K.M.A. The headaches. 2nd edition :2000;17-24 Lippincott, Williams & Wilkins, Philadelphia
2. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 41:2001;646-657
3. Johnson C.J. Headaches and facial pain. Barker L.R., Burton J.R., Zieve P.D. Principles of ambulatory medicine. 6th edition :2003;1369-1385 Lippincott, Williams & Wilkins, Philadelphia
4. Locksley H.B. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. Sahs A.L., Perret G.E., Locksley H.B., Nishioka H. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. 1969;37-57 JB Lippincott, Philadelphia
5. Olesen J., for the Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 8:(Suppl 7):1988;S1-S96
6. Lipton R.B., Stewart W.F., Cady R., Hall C., O'Quinn S., Kuhn T., et al. Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study. Headache. 40:(10):2000;783-791
7. Wall M., Silberstein S.D., Aiken R.D. Headache associated with abnormalities in intracranial structure: high cerebrospinal fluid pressure headache and brain tumor. Silberstein S.D., Lipton R.B., Dalessio D.F. Wolff's headache and other head pain. 7th edition :2001;393-416 Oxford University Press, New York
8. Chicone M.R., Dacey R.G. Jr. Clinical aspects of subarachnoid hemorrhage. Welch K.M.A., Caplan L.R., Reis D.J., Siesjo B.K., Weir B. Primer on cerebrovascular diseases. 1997;425-432 Academic Press, San Diego
9. Bousser M.G. Cerebral venous thrombosis. Welch K.M.A., Caplan L.R., Reis D.J., Siesjo B.K., Weir B. Primer on cerebrovascular diseases. 1997;385-389 Academic Press, San Diego
10. Stewart W.F., Lipton R.B., Celanto D.D., Reed M.L. Prevalence of migraine headache in the United States, relation to age, income, race, and other sociodemographic factors. JAMA. 267:1992;64-69
11. Marcus D.A. Interrelationships of neurochemicals, estrogen, and recurring headache. Pain. 62:1995;129-139
12. Edelson R.N. Menstrual migraine and other hormonal aspects of migraine. Headache. 25:1985;376-379
13. Stewart W.F., Lipton R.B., Chee E., Sawyer J., Silberstein S.D. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 55:2000;1517-1523
14. Newman L.C., Lipton R.B., Lay C.L., Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology. 51:1998;307-309
15. Newman L. A double-blind, randomized, placebo-controlled trial of naratriptan in the prophylaxis of menstrual migraine. Headache. 41:2001;248-256
16. Silberstein S.D., Lipton R.B., Goadsby P.J. Headache in clinical practice. 2002;Martin Dunitz Ltd, London. p.88
17. Silberstein S.D., Lipton R.B., Goadsby P.J. Headache in clinical practice. 2002;Martin Dunitz Ltd, London. p.104
18. Dalton K. Migraine and oral contraceptives. Headache. 16:1976;247-251
19. Massiou H., MacGregor E.A. Evolution and treatment of migraine with oral contraceptives. Cephalalgia. 20:2000;170-177
20. Bousser M.G., Conrad J., Kittner S., deLignieres B., MacGregor E.A., Massiou H., et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia. 20:2000;155-157
21. Storey J.R., Calder C.S., Hart D.E., Potter D.L. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 41:2001;968-975
22. Doose D.R., Jacobs D., Squires L., Shean-Sheng W., Bialer M. Oral contraceptive AED interactions: no effect of topiramate as monotherapy at clinically effective dosages of 200 mg or less. Epilepsia. 43:(Suppl 7):2003;S205
23. Maggioni F., Alessi C., Zanchin G. Headache during pregnancy. Cephalalgia. 17:1997;765-769
24. Aube M. Migraine in pregnancy. Neurology. 53:1999;S26
25. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 1998;Williams & Wilkins, Baltimore
26. Fox A.W., Chambers C.D., Anderson P.O., Diamond M.L., Spierings E.L.H. Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache. 42:2002;8-15
27. Cunningham F.G., Gant N.F., Leveno K.J., Gilstrap L.C., Hauth J.C., Wenstrom K.D. Williams obstetrics. 21st edition :2001;McGraw-Hill, New York. p. 570
28. Cunningham F.G., Gant N.F., Leveno K.J., Gilstrap L.C., Hauth J.C., Wenstrom K.D. Williams obstetrics. 21st edition :2001;McGraw-Hill, New York. p. 1406
29. Lance J.W., Goadsby P.J. Mechanism and management of headache. 6th edition :1998;Butterworth Heinemann, Oxford. p. 258-9
30. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 93:1994;137-150